CorEvitas Alopecia Areata (AA) Safety and Effectiveness Registry

Recruiting now

Conditions studied: Alopecia Areata

In brief

Prospective, observational cohort study for subjects with AA under the care of a dermatology provider. Approximately 5,000 subjects and 100 clinical sites in North America will be recruited to participate with no defined upper limit for either target.

Key facts

Study ID

NCT05745389

Run by

CorEvitas

People needed

5000

Starts

2022-10-25

Expected to finish

2099-12-31

Last updated by the study team

2026-02-09

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• A subject must meet all the following criteria to participate in the registry:
• Has been diagnosed with alopecia areata by a dermatologist or a qualified dermatology practitioner.
• Is at least 18 years of age or older.
• Is willing to provide Personal Information.
• Is prescribed or starting an Enrollment Eligible Medication at the time of enrollment.

You may not qualify if…

• Any of the following would exclude the subject from participating in the registry:
• Is participating or planning to participate in a double-blind randomized trial for an AA drug. Note:
• Concurrent participation in another observational registry or open-label Phase 3b/4 trial is allowed.

Where it is running

• CorEvitas, LLC — Waltham, Massachusetts, United States (enrolling)

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.